Optimal control strategy for cancer remission using combinatorial therapy: A mathematical model-based approach

Abstract In this article, we develop and analyze a non-linear mathematical model of tumor-immune interactions with combined therapeutic drug and treatment controls. To understand under what circumstances the cancerous cells can be destroyed, an optimal control problem is formulated with treatments as control parameters. By designing a quadratic control based functional, we establish the optimal treatment strategies that maximize the number of immune-effector cells, minimize the number of cancer cells, and detrimental effects caused by the amount of drugs. The necessary and sufficient conditions for optimal control are established. We prove the existence and uniqueness of an optimal control problem. To recognize significant system’s parameters, sensitivity analysis are performed for the drug administration and cost functional respectively. We also carry out a cost-effectiveness analysis to determine the most cost-effective therapeutic strategy. The numerical results validate analytical findings and also elucidates that the combinatorial drug therapy can alleviate the cancerous cells under different scenarios.

[1]  Parthasakha Das,et al.  An investigation on Monod-Haldane immune response based tumor-effector-interleukin-2 interactions with treatments , 2019, Appl. Math. Comput..

[2]  D. Kirschner,et al.  Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.

[3]  Shanmugam Lakshmanan,et al.  Optimal control of tumour-immune model with time-delay and immuno-chemotherapy , 2019, Appl. Math. Comput..

[4]  A. Perelson,et al.  Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis. , 1994, Bulletin of mathematical biology.

[5]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[6]  D. Noonan,et al.  Tumor inflammatory angiogenesis and its chemoprevention. , 2005, Cancer research.

[7]  John T. Workman,et al.  Optimal Control Applied to Biological Models , 2007 .

[8]  Dibakar Ghosh,et al.  The influence of time delay in a chaotic cancer model. , 2018, Chaos.

[9]  Yue Zhao,et al.  Survival analysis for tumor cells in stochastic switching environment , 2019, Appl. Math. Comput..

[10]  R. Weinberg,et al.  The Biology of Cancer , 2006 .

[11]  Jon Ernstberger,et al.  OPTIMAL CONTROL APPLIED TO IMMUNOTHERAPY , 2003 .

[12]  A. Misra,et al.  Stochastic stability of aerosols-stimulated rainfall model , 2019, Physica A: Statistical Mechanics and its Applications.

[13]  G. W. Swan Role of optimal control theory in cancer chemotherapy. , 1990, Mathematical biosciences.

[14]  Parthasakha Das,et al.  Stochastic dynamics of Michaelis–Menten kinetics based tumor-immune interactions , 2020 .

[15]  Parthasakha Das,et al.  Effects of delayed immune-activation in the dynamics of tumor-immune interactions , 2020, Mathematical Modelling of Natural Phenomena.

[16]  P. Maini,et al.  Mathematical oncology: Cancer summed up , 2003, Nature.

[17]  Carla M. A. Pinto,et al.  The effect of aggressive chemotherapy in a model for HIV/AIDS-cancer dynamics , 2019, Commun. Nonlinear Sci. Numer. Simul..

[18]  J. Schneck,et al.  Adoptive T Cell Immunotherapy for Cancer , 2015, Rambam Maimonides medical journal.

[19]  Kazeem O. Okosun,et al.  Optimal control strategies and cost-effectiveness analysis of a malaria model , 2013, Biosyst..

[20]  L. Coussens,et al.  Paradoxical roles of the immune system during cancer development , 2006, Nature Reviews Cancer.

[21]  F Castiglione,et al.  Cancer immunotherapy, mathematical modeling and optimal control. , 2007, Journal of theoretical biology.

[22]  Ranjit Kumar Upadhyay,et al.  Optimal treatment strategies for delayed cancer-immune system with multiple therapeutic approach , 2020 .

[23]  L. S. Pontryagin,et al.  Mathematical Theory of Optimal Processes , 1962 .

[24]  Kusum Lata,et al.  An optimal control problem for carrier dependent diseases , 2020, Biosyst..

[25]  Parthasakha Das,et al.  Dynamics and control of multidrug-resistant bacterial infection in hospital with multiple delays , 2020, Commun. Nonlinear Sci. Numer. Simul..

[26]  M. Raffeld,et al.  Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes , 2002, Science.

[27]  A. Murugan,et al.  Chemotherapy for tumors: an analysis of the dynamics and a study of quadratic and linear optimal controls. , 2007, Mathematical biosciences.

[28]  J. F. Gómez‐Aguilar,et al.  A chaos study of tumor and effector cells in fractional tumor-immune model for cancer treatment , 2020 .

[29]  M. Perry The Chemotherapy Source Book , 1992, Annals of Internal Medicine.

[30]  John Carl Panetta,et al.  Optimal Control Applied to Competing Chemotherapeutic Cell-Kill Strategies , 2003, SIAM J. Appl. Math..

[31]  Fathalla A. Rihan,et al.  Dynamics of fractional-order delay differential model for tumor-immune system , 2020 .

[32]  Sylvain Mangiarotti,et al.  How tumor growth can be influenced by delayed interactions between cancer cells and the microenvironment? , 2017, Biosyst..

[33]  A. Radunskaya,et al.  Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .

[34]  Parthasakha Das,et al.  Dynamics of Effector -Tumor- Interleukin-2 Interactions with Monod-Haldane Immune Response and Treatments , 2019, ICITAM.

[35]  A. Misra,et al.  The influence of forestry resources on rainfall: A deterministic and stochastic model , 2020 .

[36]  Ranjit Kumar Upadhyay,et al.  Exploring dynamical complexity in a time-delayed tumor-immune model. , 2020, Chaos.

[37]  Ami Radunskaya,et al.  The dynamics of an optimally controlled tumor model: A case study , 2003 .

[38]  An optimal control model for cloud seeding in a deterministic and stochastic environment , 2020, Optimal Control Applications and Methods.

[39]  Behzad Ghanbari,et al.  A study of behaviour for immune and tumor cells in immunogenetic tumour model with non-singular fractional derivative , 2020 .

[40]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[41]  P. Das,et al.  Control of Nipah virus outbreak in commercial pig-farm with biosecurity and culling , 2020, Mathematical Modelling of Natural Phenomena.

[42]  R. Schreiber,et al.  Cancer immunoediting: from immunosurveillance to tumor escape , 2002, Nature Immunology.

[43]  G. W. Swan,et al.  General applications of optimal control theory in cancer chemotherapy. , 1988, IMA journal of mathematics applied in medicine and biology.

[44]  Hongming Zhang,et al.  Current status and future directions of cancer immunotherapy , 2018, Journal of Cancer.

[45]  Parthasakha Das,et al.  An investigation on Michaelis - Menten kinetics based complex dynamics of tumor - immune interaction , 2019, Chaos, Solitons & Fractals.

[46]  A. Diefenbach,et al.  Rae1 and H60 ligands of the NKG2D receptor stimulate tumour immunity , 2001, Nature.

[47]  C. Maley,et al.  Cancer is a disease of clonal evolution within the body1–3. This has profound clinical implications for neoplastic progression, cancer prevention and cancer therapy. Although the idea of cancer as an evolutionary problem , 2006 .

[48]  Dibakar Ghosh,et al.  A chemotherapy combined with an anti-angiogenic drug applied to a cancer model including angiogenesis , 2017 .

[49]  W. Fleming,et al.  Deterministic and Stochastic Optimal Control , 1975 .

[50]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[51]  K Renee Fister,et al.  Immunotherapy: an optimal control theory approach. , 2005, Mathematical biosciences and engineering : MBE.

[52]  Santo Banerjee,et al.  Characterizing chaos and multifractality in noise-assisted tumor-immune interplay , 2020, Nonlinear Dynamics.

[53]  A. Hoos Evolution of end points for cancer immunotherapy trials. , 2012, Annals of oncology : official journal of the European Society for Medical Oncology.

[54]  R. Schreiber,et al.  Natural innate and adaptive immunity to cancer. , 2011, Annual review of immunology.

[55]  Dibakar Ghosh,et al.  The combined effects of optimal control in cancer remission , 2015, Appl. Math. Comput..

[56]  Dahlard L. Lukes,et al.  Differential Equations: Classical to Controlled , 2012 .

[57]  Zijian Liu,et al.  Analysis of a nonlinear age-structured tumor cell population model , 2019, Nonlinear Dynamics.

[58]  Kusum Lata,et al.  Modeling the effect of time delay on the conservation of forestry biomass , 2013 .